DNA vaccination against neu reduces breast cancer incidence and metastasis in mice.
Reads0
Chats0
TLDR
Preclinical data indicate that therapeutic vaccination of patients with ELVIS-neu may reduce metastasis from HER2/neu-expressing breast and ovarian tumors.Abstract:
The gene for HER2/neu is overexpressed in 30–40% of breast and ovarian cancers, and this overexpression correlates with increased metastasis and poor prognosis. The HER2/neu gene product, a transmembrane protein kinase member of the EGF receptor family, has significant potential as a tumor antigen for vaccination. We inserted the sequence for neu into a novel plasmid called ELVIS containing a Sindbis virus replicon that reproduces multiple copies of mRNA. Mice vaccinated one time intramuscularly demonstrated a strong antibody response against A2L2, a murine breast cancer cell line transfected to express neu. Vaccinated mice challenged in the mammary fatpad with A2L2 had reduced tumor incidence and reduced tumor mass compared to mice challenged with tumor cells lacking the neu insert. Intradermal vaccination was also protective and required 80% less plasmid for a similar level of protection. Vaccination reduced the incidence of lung metastasis from mammary fatpad tumors and reduced the number of lung metastases resulting from intravenous injection of A2L2 cells. Cytotoxic T lymphocytes cultures of immune spleen cells with P815-neu cells produced high levels of interferon-γ indicating an antigen-specific Th1-type immune response resulting from the vaccination. In a spontaneous breast tumor model using neu transgenic mice, vaccination with ELVIS-neu protected against development of spontaneous breast tumors. Our preclinical data indicate that therapeutic vaccination of patients with ELVIS-neu may reduce metastasis from HER2/neu-expressing breast and ovarian tumors. Cancer Gene Therapy (2001) 8, 259–268read more
Citations
More filters
Journal ArticleDOI
Prospects for cationic polymers in gene and oligonucleotide therapy against cancer
TL;DR: This review will introduce the most important cationic polymers used as non-viral vectors for gene and oligonucleotide delivery and will summarize strategies for the targeting of these agents to cancer tissues.
Journal ArticleDOI
Mechanism of T Cell Tolerance Induced by Myeloid-Derived Suppressor Cells
TL;DR: Using double TCR transgenic CD8+ T cells, it is demonstrated that MDSC induced tolerance to only the peptide, which was presented by MDSCs, which caused dissociation between TCR and CD3ζ molecules, disrupting TCR complexes on T cells.
Journal ArticleDOI
Reprogrammed FoxP3+ T Regulatory Cells Become IL-17+ Antigen-Specific Autoimmune Effectors In Vitro and In Vivo
Suresh Radhakrishnan,Rosalyn Cabrera,Erin L. Schenk,Pilar Nava-Parada,Michael P. Bell,Virginia P. Van Keulen,Ronald J. Marler,Sara J. Felts,Larry R. Pease +8 more
TL;DR: The finding that mature Tregs can be reprogrammed into competent effector cells provides new insights into the plasticity of T cell lineage, underscores the importance of DC-T cell interaction in balancing immunity with tolerance, points to TregS as a reservoir of autoimmune effectors, and defines a new approach for breaking tolerance to self Ags as a strategy for cancer immunotherapy.
Journal ArticleDOI
Peptide Vaccine Given with a Toll-Like Receptor Agonist Is Effective for the Treatment and Prevention of Spontaneous Breast Tumors
TL;DR: The results show that to obtain tumor antigen-specific CTL responses and antitumor effects, the vaccine had to be administered repetitively, or the function of CD4/CD25 T regulatory cells had to been blocked with anti-CD25 antibody therapy.
Journal ArticleDOI
Self-replicating alphavirus RNA vaccines
Karl Ljungberg,Peter Liljeström +1 more
TL;DR: This review discusses self-replicating RNA vaccines developed from alphavirus expression vectors, which have been pre-clinically evaluated as vaccines against a number of infectious diseases and cancer.
References
More filters
Journal ArticleDOI
Direct gene transfer into mouse muscle in vivo.
Jon A. Wolff,Robert W. Malone,Phillip Williams,Wang Chong,Gyula Acsadi,Agnes Jani,Philip L. Felgner +6 more
TL;DR: RNA and DNA expression vectors containing genes for chloramphenicol acetyltransferase, luciferase, and beta-galactosidase were separately injected into mouse skeletal muscle in vivo and expression was comparable to that obtained from fibroblasts transfected in vitro under optimal conditions.
Journal ArticleDOI
DNA vaccines: immunology, application, and optimization*.
TL;DR: This review focuses on the mechanisms by which DNA vaccines elicit immune responses, and a list of potential applications in a variety of preclinical models is provided.
Journal ArticleDOI
Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease
Chantale T. Guy,Marc A. Webster,Michael Schaller,Thomas J. Parsons,Robert D. Cardiff,William J. Muller +5 more
TL;DR: Overexpression of the unactivated neu protein can induce metastatic disease after long latency and is associated with elevated neu intrinsic tyrosine kinase activity and the de novo tyrosinesine phosphorylation of several cellular proteins.
Journal ArticleDOI
Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene
TL;DR: The results indicate that the combination of activated oncogene and tissue context are major determinants of malignant progression and that expression of the activated form of c-neu in the mammary epithelium has particularly deleterious consequences.
Journal ArticleDOI
Combination Immunotherapy of B16 Melanoma Using Anti–Cytotoxic T Lymphocyte–Associated Antigen 4 (Ctla-4) and Granulocyte/Macrophage Colony-Stimulating Factor (Gm-Csf)-Producing Vaccines Induces Rejection of Subcutaneous and Metastatic Tumors Accompanied by Autoimmune Depigmentation
TL;DR: This study shows that CTLA-4 blockade provides a powerful tool to enhance T cell activation and memory against a poorly immunogenic spontaneous murine tumor and that this may involve recruitment of autoreactive T cells.
Related Papers (5)
A new generation of animal cell expression vectors based on the Semliki Forest virus replicon.
Peter Liljeström,Henrik Garoff +1 more